• May 03, 2018

    Update on Vaginitis - 2018 (On Demand)

    Non Member: $0.00

    Update on Vaginitis - 2018

    Release Date: May 9, 2018
    Expiration Date: 
    May 9, 2021

    Although the topic of vaginitis is often trivialized, it causes significant discomfort and symptoms for women who suffer from either acute or chronic vaginitis.  In this presentation, Dr. Nyirjesy will summarize the overall evaluation of women with vaginal complaints and discuss the benefits and limitations of various testing modalities.  This section will be followed by a discussion of the most common causes of infectious vaginitis (bacterial vaginosis, trichomoniasis, and vulvovaginal candidiasis) and of desquamative inflammatory vaginitis, with management tips for managing both acute and chronic cases.



    Paul Nyirjesy, MD

    Dr. Paul Nyirjesy is Professor of Obstetrics and Gynecology and of Medicine at Drexel University College of Medicine in Philadelphia, Pennsylvania. In addition, he is director of the Drexel Vaginitis Center.  Dr. Nyirjesy earned his BA in Chemistry magna cum laude at Amherst College in Amherst, Massachusetts, and his MD at Georgetown University School of Medicine in Washington, DC. After graduating, he completed his residency in obstetrics and gynecology at Thomas Jefferson University Hospital and a fellowship in infectious diseases in the department of medicine at Temple University Hospital.  Dr. Nyirjesy has authored or coauthored many articles, abstracts, and monographs concerning vaginal infections and vulvar diseases.  A fellow of American College of Obstetrics and Gynecology, he is also a member of the Infectious Diseases Society of America, the International Society for the Study of Vulvovaginal Diseases and the Infectious Diseases Society for Obstetrics and Gynecology.


    Target Audience

    This activity is intended for physicians, physician assistants and nurse practitioners working in obstetrics and gynecology, gynecology, dermatology, family medicine and general practice.


    Educational Objectives

    Upon completion of this educational activity, participants should be able to:

    • Do an appropriate work-up of a woman with vulvovaginal symptoms;
    • Have an appreciation for limitations of various testing modalities for vaginal infections;
    • Treat uncomplicated and complicated vulvovaginal candidiasis, bacterial vaginosis, trichomoniasis and desquamative inflammatory vaginitis.


    Continuing Medical Education Credit

    Accreditation Statement

    The ASCCP is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Physician Credit Designation

    ASCCP designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Disclosure Information

    As an accredited provider of CME credit, ASCCP is required to comply with the ACCME's Standards for Commercial Support and has implemented a management process to ensure that anyone in a position to affect the content of the educational activity (e.g., faculty, planners, etc.) disclosed all relevant financial relationships with a commercial interest and ensured that those relationships do not influence presentation materials. All faculty have agreed to base their presentations on best available evidence. ASCCP discloses to learners any financial relationship(s) to healthcare-related commercial interests existing within the past 12 months to include the following information: 

    1. the name of the individual;
    2. the name of the commercial interest; and,
    3. the nature of the relationship the person has with each commercial interest.

    Slides and slide notes are reviewed for possible bias prior to the activity's release, and potential conflicts of interest are resolved prior to the presentation. Any discussion of off-label use of products is noted when appropriate, as is discussion of any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Disclosures of these commitments and/or relationships are published in these lecture materials and provided prior to the start of the activity, so the learners may formulate their own judgments regarding the presentation(s). Under ASCCP policy, anyone declining either to disclose or amend material to eliminate potential bias will be replaced.

    Author, Reviewer, and Planner Disclosure Information:

    The following person(s) disclose the following financial relationships:

    • Paul Nyirjesy, MD
      • Viamet Pharmaceuticals, Consultant
      • Symbiomix Therapeutics, Consultant
      • Evofem, Consultant
      • Scynexis Inc., Consultant and Investigator
      • Curatek Pharmaceuticals, Investigator

    The following person(s) disclose no relevant financial relationships:

    • Patricia Cason, FNP, ASCCP Education Committee Chair
    • Peter F. Schnatz, DO , ASCCP Education Committee Co-Chair
    • Amy Wiser, MD, ASCCP Education Committee 
    • Christina Arnold, Education Manager, ASCCP
    • Kerry Curtis, CEO, ASCCP
    • Jill Leonard, Project Manager, ASCCP
    • Cari Price, Managing Director, ASCCP
    • Alisha Yocum, Director of Membership and Marketing, ASCCP

    This webinar is partially supported by an independent education grant from BD Diagnostics.

Privacy Policy:


By using this site, you agree to the Privacy Policy and acknowledge the use of cookies to store information, which may be essential to making our site work properly or enhancing user experience.